Nanotechnology-based solutions have shown significant promise in reducing thrombus formation. Studies have demonstrated that nanoscale modifications can dramatically improve the hemocompatibility of medical devices. For instance, surfaces modified with carbon nanotubes or graphene have shown reduced platelet adhesion and activation, leading to lower clot formation rates.
